Mounjaro and Wegovy: Who Are They Suitable For, and Who Should Avoid Them?

Weight-loss

injection medications,

Mounjaro (Mounjaro,

tirzepatide)

and Wegovy (Wegovy,

semaglutide), are

currently attracting

global attention.

Both medications belong to

the GLP-1 class and help

with weight loss by

suppressing appetite and

controlling blood sugar.

Mounjaro acts on

both GLP-1 and GIP,

making it a

"dual agonist."

Wegovy, by contrast, is a

"GLP-1-only agonist."

However,

Mounjaro and Wegovy

are not suitable for

everyone,

so to maximize the

effects and minimize

side effects,

it is important to

carefully determine

whether they are right for you.

Let’s look at

who Mounjaro and Wegovy

are suitable for,

and when they should

be avoided.

On the other hand, when

should a prescription for

Mounjaro or Wegovy be

avoided?

If, while taking the medication,

severe

abdominal pain, vomiting,

fever, or other

symptoms

that may suggest

pancreatitis occur,

you should stop taking the

medication immediately

and inform a healthcare professional.

Hypersensitivity reactions

may appear as severe

allergic symptoms such as

hives, difficulty breathing,

or swelling of the face or throat,

and may require immediate

medical attention.

Mounjaro and Wegovy are

highly effective medications,

but for safety,

a precise diagnosis and

prescription from a doctor

must be followed.

It is very important to

share your health status and

past medical history in detail

with a healthcare professional,

and to discuss the possibility

of side effects thoroughly.